Tumor-targeted induction of oxystress for cancer therapy.
about
HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulationA new view of carcinogenesis and an alternative approach to cancer therapyAntioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal ResultsDownregulation of tumor growth and invasion by redox-active nanoparticlesThe "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancerHigh-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trialThe effect of zinc and the role of p53 in copper-induced cellular stress responses.Over-expression of aldehyde dehydrogenase-2 protects against H₂O₂-induced oxidative damage and apoptosis in peripheral blood mononuclear cells.Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells.Double targeting of tumours with pyrenyl-modified dendrimers encapsulated in an arene-ruthenium metallaprism.FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism.Determination of serum adenosine deaminase and xanthine oxidase levels in patients with crimean-congo hemorrhagic fever.CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1.D-amino acid oxidase-nanoparticle system: a potential novel approach for cancer enzymatic therapy.Discovery of small-molecule enhancers of reactive oxygen species that are nontoxic or cause genotype-selective cell death.G226, a new epipolythiodioxopiperazine derivative, triggers DNA damage and apoptosis in human cancer cells in vitro via ROS generation.Reactive oxygen species-dependent apoptosis by gugulipid extract of Ayurvedic medicine plant Commiphora mukul in human prostate cancer cells is regulated by c-Jun N-terminal kinase.Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients.The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress.Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.Zinc protoporphyrin polymeric nanoparticles: potent heme oxygenase inhibitor for cancer therapy.Responses of solid tumor cells in DMEM to reactive oxygen species generated by non-thermal plasma and chemically induced ROS systems.Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agentsOverexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells.Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation.Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like CellsCurcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications.Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer.c-Myc modulation: a key role in melanoma drug response.Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle.The inhibitory effect of ellagic Acid on cell growth of ovarian carcinoma cells.Radical decisions in cancer: redox control of cell growth and death.Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistryTriptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3(PT) platinum-resistant human ovarian cancer cells.Embryonic stem cells lacking the epigenetic regulator Cfp1 are hypersensitive to DNA-damaging agents and exhibit decreased Ape1/Ref-1 protein expression and endonuclease activity.Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2.
P2860
Q24310722-BFF41E4B-F227-48CA-89E4-4143BD76188AQ24650249-B579C581-2D45-41B5-8727-82D154E75F0CQ26774897-CFD0B506-6EF2-488E-BB69-73BDD62C8C18Q28387744-515A7461-F0B9-442D-B4CA-E27B05944048Q28391375-943EE48D-9C29-43B7-A0D5-DE2DF63614B2Q28545827-A39276E0-0692-46F8-9782-9BB77DBD86D5Q30427092-22FA9B25-7D1A-42D9-8B04-061EC733F797Q33565669-846123B2-CE66-486E-BCEC-0C7F245D90C3Q33668723-FE193639-CEEF-494B-8673-C0B2E271E278Q33806089-B6E8D540-1B97-448B-8F01-2EDD3CB70AA4Q33912023-D2C731D8-3EF8-4A2A-A01C-5B15BD5DF57CQ34023473-D5C99F2F-EDB0-47D0-915F-F106209EF0DFQ34299243-EDA4E4DD-1C0B-462F-92B0-E60F917308A7Q34577760-1E205364-B994-4EC2-BBB3-F09A5EA8A7C6Q34616049-37347D5B-6D65-4CD8-BA75-DFB66C93E1D9Q34664494-7561E462-2454-41D1-B131-3311265D205EQ34701035-33F075C6-2C97-4E58-A373-A6540862C2B3Q34785845-AC5FD6A0-48C9-4B19-8D07-231FFC482CF0Q34990296-5ED471E2-F624-4AE7-8BA0-60F79B69F41BQ35032472-7689090D-BD77-47A4-8243-775A28E51BCBQ35050169-B641E1BC-A3C3-4E70-B867-6361BD5CAD53Q35099351-221612DC-CB52-42F6-90A8-3563B9391556Q35123560-FE2E90A4-5FE4-468C-917B-3A6564030406Q35188164-386EA7AE-C66A-4464-AA82-56A7B4ACC6D4Q35194850-8B8E0F4A-0986-4E41-B837-5048F52CD5EDQ35222202-B0D62BEB-B251-424A-87C0-632C461D3601Q35496324-D7B7B5CA-1C93-46CA-A923-C86E9AF3A12AQ35681981-85BD78A0-D2E5-489B-9FB1-DF87B1178EA9Q35773665-83B1C492-FB31-4217-B158-5064E75802F3Q35972616-D7510554-D8A3-4979-9A0D-5EC2A18A1697Q36020882-B67A6441-1056-4DF7-AAF3-7D6B81B3F77CQ36213103-F0A0DF68-F781-4FCB-97CA-1BAAE6F305E3Q36544979-9D6D6D43-0EE8-4889-9DE4-B0EDEEDBC779Q36892008-56DD4775-3B56-49EA-A748-4D0E31F11069Q36969635-605749E8-A028-4E6E-8B39-C6BB7C4ABF3DQ37017004-657F348D-8E15-4872-991A-7C8BC9F499DAQ37206068-DC14BF6D-553E-4D6E-AD61-A3FFE1D9E119Q37229429-70FA5122-88BC-46D4-AC4D-98B51C248A29Q37455875-B053CC3E-D4A7-4F59-985E-5A6EAF5D6F2EQ37864354-891AA691-9412-485C-A851-D32C63CB27AA
P2860
Tumor-targeted induction of oxystress for cancer therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor-targeted induction of oxystress for cancer therapy.
@en
type
label
Tumor-targeted induction of oxystress for cancer therapy.
@en
prefLabel
Tumor-targeted induction of oxystress for cancer therapy.
@en
P2093
P2860
P1476
Tumor-targeted induction of oxystress for cancer therapy.
@en
P2093
P2860
P304
P356
10.1080/10611860701498286
P577
2007-08-01T00:00:00Z